Comments on: New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy https://insideout.vn/new-phase-iiib-data-shows-novartis-fabhalta-improved-hemoglobin-levels-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-who-switched-from-anti-c5-therapy/ Inside Out Fri, 06 Dec 2024 08:31:56 +0000 hourly 1 https://wordpress.org/?v=6.7.1